The prevalence of the pathogenic CHD7 variant (85%) and the ratio of truncating versus non-truncating CHD7 mutations (30%/70%) were similar in the 13 individuals with CS and autism (ADI-R), the 13 patients without autism, and the entire group of 46 patients (data not shown). The gene discussed is CHD7; the disease is autism.